Capture best practices in a macro guide for handling GLP-1 meds perioperatively
Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior weight loss and expanded therapeutic applications spanning from brain health to renal disease". For 2026, pharma executives must recognize that metabolic innovation extends far beyond replicating existing GLP-1 therapies, the report authors wrote
This occurs through the activation of adenylyl cyclase, leading to increased intracellular levels of cyclic AMP (cAMP)
Hauge C, Breitschaft A, Hartoft-Nielsen ML, Jensen S, Baekdal TA
Its effectiveness is linked to its strong binding affinity to the GLP-1 receptor and its long half-life, enabling convenient once-weekly dosing
HananAlShekar Silver Posted on Nov 26, 2025 Bahrain 209 0 4 17 Perfect